Rossana Madamba

Vince Lombardi Cancer Center at ...Elkhorn, Wisconsin - 53121 (920-288-4180) |
- CLINICAL TRIALS 5
- CONDITIONS6
- INTERVENTIONS17
- SINCE2003

Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
July 2009 - June 2012

Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
November 2003 - June 2012

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
November 2005 - June 2008

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
June 2007 - January 2010

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Colonic Neoplasms
Lung Neoplasms
Adenocarcinoma
Carcinoma, Non-Small-Cell Lung
Colorectal Neoplasms
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Docetaxel
Fluorouracil
Leucovorin Calcium
Gemcitabine Hydrochloride
Cyclophosphamide
Pemetrexed Disodium
Oxaliplatin
Doxorubicin Hydrochloride
Trastuzumab
Cetuximab
Irinotecan Hydrochloride
Ac Regimen
Vinorelbine Ditartrate



